|
Mar 14
|
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
|
|
Mar 13
|
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
|
|
Mar 12
|
Life Sciences Investor Forum Agenda Announced for March 13th
|
|
Mar 12
|
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
|
|
Mar 11
|
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
|
|
Mar 10
|
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
|
|
Feb 24
|
TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…
|
|
Jan 8
|
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
|
|
Oct 9
|
Tonix Pharma Enhances Drug Development with AI Partnership
|
|
Oct 8
|
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
|
|
Aug 6
|
Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens
|
|
Jul 30
|
Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
|
|
Jul 25
|
Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia
|
|
Jul 24
|
Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
|
|
Jun 27
|
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
|
|
Jun 26
|
Tonix Pharmaceuticals Announces Proposed Public Offering
|
|
Jun 26
|
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
|
Jun 25
|
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
|
|
Jun 21
|
7 F-Rated Penny Stocks to Avoid This June
|
|
Jun 20
|
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
|